Biocompatibility between Silicon or Silicon Carbide surface and Neural Stem Cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 08 2019
Historique:
received: 23 01 2019
accepted: 05 07 2019
entrez: 10 8 2019
pubmed: 10 8 2019
medline: 22 10 2020
Statut: epublish

Résumé

Silicon has been widely used as a material for microelectronic for more than 60 years, attracting considerable scientific interest as a promising tool for the manufacture of implantable medical devices in the context of neurodegenerative diseases. However, the use of such material involves responsibilities due to its toxicity, and researchers are pushing towards the generation of new classes of composite semiconductors, including the Silicon Carbide (3C-SiC). In the present work, we tested the biocompatibility of Silicon and 3C-SiC using an in vitro model of human neuronal stem cells derived from dental pulp (DP-NSCs) and mouse Olfactory Ensheathing Cells (OECs), a particular glial cell type showing stem cell characteristics. Specifically, we investigated the effects of 3C-SiC on neural cell morphology, viability and mitochondrial membrane potential. Data showed that both DP-NSCs and OECs, cultured on 3C-SiC, did not undergo consistent oxidative stress events and did not exhibit morphological modifications or adverse reactions in mitochondrial membrane potential. Our findings highlight the possibility to use Neural Stem Cells plated on 3C-SiC substrate as clinical tool for lesioned neural areas, paving the way for future perspectives in novel cell therapies for neuro-degenerated patients.

Identifiants

pubmed: 31395932
doi: 10.1038/s41598-019-48041-3
pii: 10.1038/s41598-019-48041-3
pmc: PMC6687690
doi:

Substances chimiques

Biocompatible Materials 0
Carbon Compounds, Inorganic 0
Silicon Compounds 0
silicon carbide WXQ6E537EW
Silicon Z4152N8IUI

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11540

Références

Stem Cell Res. 2015 Nov;15(3):722-730
pubmed: 26599327
Interv Cardiol Clin. 2019 Apr;8(2):95-109
pubmed: 30832945
PLoS One. 2015 Oct 30;10(10):e0140790
pubmed: 26517263
IEEE Trans Nanobioscience. 2009 Mar;8(1):4-12
pubmed: 19304495
Front Cell Neurosci. 2018 Jan 11;11:430
pubmed: 29375316
Brain Res Rev. 2007 Nov;56(1):236-58
pubmed: 17884174
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Tissue Eng Part A. 2009 Jul;15(7):1797-805
pubmed: 19191513
J Biomed Sci. 2009 Nov 25;16:108
pubmed: 19939265
Neurosurgery. 2010 Dec;67(6):1733-44
pubmed: 21107205
Circ Res. 2004 Jul 9;95(1):9-20
pubmed: 15242981
J Neurosci Methods. 2015 Aug 15;251:143-50
pubmed: 26051555
PLoS One. 2016 Mar 31;11(3):e0152566
pubmed: 27031101
Stem Cell Rev Rep. 2016 Apr;12(2):224-34
pubmed: 26553037
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:2957-60
pubmed: 22254961
IEEE Trans Neural Syst Rehabil Eng. 2003 Jun;11(2):189-92
pubmed: 12899271
Front Physiol. 2017 Mar 28;8:177
pubmed: 28400736
Biomaterials. 2011 Sep;32(26):6068-79
pubmed: 21636129
Cell Tissue Res. 2008 Jan;331(1):301-22
pubmed: 17901985
J Rehabil Res Dev. 1999 Oct;36(4):371-6
pubmed: 10678460
Biomed Microdevices. 2013 Apr;15(2):353-68
pubmed: 23319268
J Neural Eng. 2015 Feb;12(1):011001
pubmed: 25460808
Med Mol Morphol. 2015 Dec;48(4):214-24
pubmed: 25982872
J Dent. 2014 Jul;42(7):761-8
pubmed: 24589847
Bioelectron Med (Lond). 2018 Dec;1(4):251-263
pubmed: 33859830
Front Biosci (Schol Ed). 2010 Jan 01;2(1):289-98
pubmed: 20036947
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13625-30
pubmed: 11087820
Cell Transplant. 2015;24(7):1283-97
pubmed: 24911956
Differentiation. 2009 Jan;77(1):29-37
pubmed: 19281762
Nat Med. 2018 May;24(4):484-490
pubmed: 29480894
Neural Regen Res. 2018 Jan;13(1):35-42
pubmed: 29451202
Neurotoxicology. 2018 Jul;67:84-93
pubmed: 29698629
Arch Neurol. 2008 May;65(5):612-6
pubmed: 18474736
J Mater Sci Mater Med. 2013 Feb;24(2):281-94
pubmed: 23183961

Auteurs

Gabriele Bonaventura (G)

Institute for Biomedical Research and Innovation, Italian National Research Council, Catania, Italy.

Rosario Iemmolo (R)

Institute for Biomedical Research and Innovation, Italian National Research Council, Catania, Italy.

Valentina La Cognata (V)

Institute for Biomedical Research and Innovation, Italian National Research Council, Catania, Italy.

Massimo Zimbone (M)

Institute for Microelectronics and Microsystems, Italian National Research Council, Catania, Italy.

Francesco La Via (F)

Institute for Microelectronics and Microsystems, Italian National Research Council, Catania, Italy.

Maria Elena Fragalà (ME)

Department of Chemical Sciences, University of Catania, Catania, Italy.

Maria Luisa Barcellona (ML)

Department of Pharmaceutical Sciences, University of Catania, Catania, Italy.

Rosalia Pellitteri (R)

Institute for Biomedical Research and Innovation, Italian National Research Council, Catania, Italy.

Sebastiano Cavallaro (S)

Institute for Biomedical Research and Innovation, Italian National Research Council, Catania, Italy. sebastiano.cavallaro@cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH